Sernova Biotherapeutics (SVA.TO) Q2 2026 Earnings

Jun 12Confirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-0.02
-0.01
-0.01
-0.01

Details

Expected EPS
-0.0102902359
Actual EPS
-0.0102902359
Surprise EPS
0
Surprise Percent
+0%

Description

⁨Sernova Biotherapeutics⁩ (⁦SVA.TO⁩) has reported earnings of ⁦-0.0102902359⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts